News coverage about Biomed Realty Trust (NYSE:BMR) has been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Biomed Realty Trust earned a coverage optimism score of 0.23 on Accern’s scale. Accern also assigned news headlines about the real estate investment trust an impact score of 45.4840421009102 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Biomed Realty Trust (BMR) traded up $0.04 during trading on Wednesday, reaching $23.81. 11,841,100 shares of the company’s stock traded hands, compared to its average volume of 7,187,771. Biomed Realty Trust has a 1-year low of $17.94 and a 1-year high of $25.08.

COPYRIGHT VIOLATION WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Biomed Realty Trust (BMR) Share Price” was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at

About Biomed Realty Trust

BioMed Realty Trust, Inc operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company’s tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry.

Insider Buying and Selling by Quarter for Biomed Realty Trust (NYSE:BMR)

Receive News & Ratings for Biomed Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomed Realty Trust and related companies with's FREE daily email newsletter.